BellaVie SKINOSAL

Coming soon

• ​100% Belgian production 
• Live strains: All our formulas have been developed with microbiotic strains, which are living bacteria.
• Innovative formula: the formula has been developed for specific uses. The product contains microbiotic strains, fibers and nutraceuticals well described scientifically for specific health benefits.
• Broad spectrum: CFU = Colony Forming Units which allows to estimate the number of viable bacteria in a sample.
• High concentration: each capsule contains a large amount of live microorganisms. The quantity is indicated in CFU (Colony Forming Units). Each capsule contains 10,000,000,000 CFU.
• Vegetable capsules and Halal certification: the capsules are certified vegan, Halal and Kosher. 
• Gastro-resistant capsules: to protect the microbiotic strains from the acidity of the stomach, we use specific capsules with a superior resistance to this acidity. The quantity of living microbiotic strains in the intestine will therefore be higher. 
• Specific nutraceuticals: the nutraceuticals are chosen according to the desired action. 
• Heat resistant strains: Bacillus Coagulans is a world-renowned strain that provides optimal temperature resistance up to zone 4B. This zone indicates a very humid and intense climate.
• Moisture resistant packaging: our packaging (capsule and blister) with low moisture content has been selected to preserve the microbiotic strains against moisture and allow them to live longer.

1 capsule per day to be taken with a large glass of water.

Possibility to increase to 1 capsule twice a day if needed or as recommended.

BellaVie capsules can be taken at any time of the day.

Store in a cool, dry place.

Refrigeration is recommended whenever possible.

As capsules contain dried live microorganisms, it is recommended to avoid large temperature and humidity variations.

Keep out of reach of children.

No adverse side effects have been reported.

Cautions: If your child has any medical conditions or is taking any prescription medications, consult your doctor before using this product. Do not exceed the indicated daily dose. This nutritional supplement is not a substitute for a varied and balanced diet and a healthy lifestyle.

Do not use if other foodstuffs containing 2'-fucosyllactose are consumed on the same day

References:

1.     Aafa.org. 2022. Allergies and Allergic Reactions | AAFA.org | AAFA | Allergies. https://www.aafa.org/allergies.aspx

2.     Cleveland Clinic. 2022. Allergies: Types, Symptoms, Causes & Treatments. https://my.clevelandclinic.org/health/diseases/8610-allergy-overview

3.     Michail, S., 2009. The role of Probiotics in allergic diseases. Allergy, Asthma & Clinical Immunology, 5(1).

4.     Du, X., Wang, L., Wu, S., Yuan, L., Tang, S., Xiang, Y., Qu, X., Liu, H., Qin, X. and Liu, C., 2019. Efficacy of probiotic supplementary therapy for asthma, allergic rhinitis, and wheeze: a meta-analysis of randomized controlled trials. Allergy and Asthma Proceedings, 40(4), pp.250-260.

5.     RDN, C., 2022. Probiotics for Asthma: An Update - International Probiotics Association. International Probiotics Association. https://internationalprobiotics.org/asthma/

6.     National Eczema Association. 2022. Probiotics: The Search for Bacterial Balance. https://nationaleczema.org/search-bacterial-balance/

7.     Jensen, G., Cash, H., Farmer, S. and Keller, D., 2017. Inactivated probiotic <em>Bacillus coagulans</em> GBI-30 induces complex immune activating, anti-inflammatory, and regenerative markers in vitro. Journal of Inflammation Research, Volume 10, pp.107-117.

8.     Proquest.com. 2022. ANTI-INFLAMMATORY AND IMMUNOMODULATORY EFFECTS OF BACILLUS COAGULANS UNIQUE IS2 - ProQuest https://www.proquest.com/openview/de2d19fcfbb134900ca10fcaba87f0b7/1?pq-origsite=gscholar&cbl=136102 .

9.     2022. [online] Available at: https://www.karger.com/Article/FullText/515352 .

10.   Cukrowska, B., Ceregra, A., Maciorkowska, E., Surowska, B., Zegadło-Mylik, M., Konopka, E., Trojanowska, I., Zakrzewska, M., Bierła, J., Zakrzewski, M., Kanarek, E. and Motyl, I., 2021. The Effectiveness of Probiotic Lactobacillus rhamnosus and Lactobacillus casei Strains in Children with Atopic Dermatitis and Cow’s Milk Protein Allergy: A Multicenter, Randomized, Double Blind, Placebo Controlled Study. Nutrients, 13(4), p.1169. - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066586/

11.   Wickens, K., Black, P., Stanley, T., Mitchell, E., Barthow, C., Fitzharris, P., Purdie, G. and Crane, J., 2012. A protective effect of L<i>actobacillus rhamnosus</i>HN001 against eczema in the first 2 years of life persists to age 4 years. Clinical &amp; Experimental Allergy, 42(7), pp.1071-1079. - https://pubmed.ncbi.nlm.nih.gov/22702506/

12.   Elmadfa, I., Klein, P. and Meyer, A., 2010. Immune-stimulating effects of lactic acid bacteria <i>in vivo</i> and <i>in vitro</i>. Proceedings of the Nutrition Society, 69(3), pp.416-420.  -  https://www.cambridge.org/core/journals/proceedings-of-the-nutrition-society/article/immunestimulating-effects-of-lactic-acid-bacteria-in-vivo-and-in-vitro/072C2E5023504BFC338584413A3C1AF2

13.   Jing, W., Liu, Q. and Wang, W., 2020. <i>Bifidobacterium bifidum</i> TMC3115 ameliorates milk protein allergy in by affecting gut microbiota: A randomized double‐blind control trial. Journal of Food Biochemistry, 44(11). – <No study/No link in the power point>

14.   Niers, L., Timmerman, H., Rijkers, G., Bleek, G., Uden, N., Knol, E., Kapsenberg, M., Kimpen, J. and Hoekstra, M., 2005. Identification of strong interleukin-10 inducing lactic acid bacteria which down-regulate T helper type 2 cytokines. Clinical &lt;html_ent glyph="@amp;" ascii="&amp;amp;"/&gt; Experimental Allergy, 35(11), pp.1481-1489. - https://pubmed.ncbi.nlm.nih.gov/16297146/

15.   Mendes, E., Acetturi, B., Thomas, A., Martins, F., Crisma, A., Murata, G., Braga, T., Camâra, N., Franco, A., Setubal, J., Ribeiro, W., Valduga, C., Curi, R., Dias-Neto, E., Tavares-de-Lima, W. and Ferreira, C., 2017. Prophylactic Supplementation of Bifidobacterium longum 51A Protects Mice from Ovariectomy-Induced Exacerbated Allergic Airway Inflammation and Airway Hyperresponsiveness. Frontiers in Microbiology, 8. - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604069/

16.   Ren, J., Zhao, Y., Huang, S., Lv, D., Yang, F., Lou, L. ... Bachert, C. (2018). Immunomodulatory effect of Bifidobacterium breve on experimental allergic rhinitis in BALB/c mice. Experimental and Therapeutic Medicine, 16, 3996-4004. https://www.spandidos publications.com/10.3892/etm.2018.6704

17.   Kekkonen, R., Kajasto, E., Miettinen, M., Veckman, V., Korpela, R. and Julkunen, I., 2008. Probiotic Leuconostoc mesenteroides ssp. cremoris and Streptococcus thermophilus induce IL-12 and IFN-γ production. World Journal of Gastroenterology, 14(8), p.1192. - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2690666/

18.   Morisset, M., Aubert-Jacquin, C., Soulaines, P., Moneret-Vautrin, D. and Dupont, C., 2010. A non-hydrolyzed, fermented milk formula reduces digestive and respiratory events in infants at high risk of allergy. European Journal of Clinical Nutrition, 65(2), pp.175-183. - https://pubmed.ncbi.nlm.nih.gov/21081959/

19.   FARID, R., 2004. Selenium status is decreased in patients with allergic diseases*1A new focus on an old trace element as a possible modifier of Th1/Th2 dichotomy. Journal of Allergy and Clinical Immunology, 113(2), p.S161. - https://doi.org/10.1016/j.jaci.2004.01.010.

20.   Richards, L., 2022. Allergies: Types, Symptoms, Causes & Treatments. [online] Cleveland Clinic. Available at: https://my.clevelandclinic.org/health/diseases/8610-allergy-overview

21.   Du, X., Wang, L., Wu, S., Yuan, L., Tang, S., Xiang, Y., Qu, X., Liu, H., Qin, X. and Liu, C., 2019. Efficacy of probiotic supplementary therapy for asthma, allergic rhinitis, and wheeze: a meta-analysis of randomized controlled trials. Allergy and Asthma Proceedings, 40(4), pp.250-260. - https://pubmed.ncbi.nlm.nih.gov/31262380/

22.   Malik, A., Menon, B., Dar, Y., Garg, T., Bhatia, H. and Kaur, C., 2015. Placebo controlled trial of vitamin D supplementation in allergic rhinitis. 5.3 Allergy and Immunology,.  - https://erj.ersjournals.com/content/46/suppl_59/PA2559

23.   Shishehbor F., Behroo L., Broujerdnia M.G., Namjoyan F., Latifi S.-M. Quercetin effectively quells peanut-induced anaphylactic reactions in the peanut sensitized rats. Iran. J. Allergy Asthma Immunol. 2010;9:27–34. [PubMed] [Google Scholar] - <No study/No link in the power point>

24.   Oliveira T.T., Campos K.M., Cerqueira-Lima A.T., Carneiro T.C.B., da Silva Velozo E., Melo I.C.A.R., Figueiredo E.A., de Jesus Oliveira E., de Vasconcelos D.F.S.A., Pontes-de-Carvalho L.C., et al. Potential therapeutic effect of Allium cepa L. and quercetin in a murine model of Blomia tropicalis induced asthma. DARU J. Pharm. Sci. 2015;23 doi: 10.1186/s40199-015-0098-5. [PMC free article] [PubMed]. - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4344790/

25.   Rogerio A., Kanashiro A., Fontanari C., da Silva E., Lucisano-Valim Y., Soares E., Faccioli L. Anti-inflammatory activity of quercetin and isoquercitrin in experimental murine allergic asthma. Inflamm. Res. 2007;56:402–408. doi: 10.1007/s00011-007-7005-6. - https://pubmed.ncbi.nlm.nih.gov/18026696/

26.   Kimata M., Shichijo M., Miura T., Serizawa I., Inagaki N., Nagai H. Effects of luteolin, quercetin and baicalein on immunoglobulin E-mediated mediator release from human cultured mast cells. Clin. Exp. Allergy. 2000;30:501–508. doi: 10.1046/j.1365-2222.2000.00768.x. -   https://pubmed.ncbi.nlm.nih.gov/10718847/